Ä·ÇÁ¾È³» ½Ç½À ÇÁ·Î±×·¥ Âü°¡½Åû Àå¼Ò¾È³» »çÁø¾Ù¹ü Âü°¡Èıâ
 

ÇÁ·Î±×·¥
  ¡Ø ¼¼ºÎÀÏÁ¤Àº »çÁ¤»ó º¯°æµÉ ¼ö ÀÖ½À´Ï´Ù.

1ÀÏÂ÷ (7¿ù 13ÀÏ, ¿ù) Prologue (Àå¼Ò: ºÎ»ê¹éº´¿ø ±¹Á¦È­»óȸÀǽÇ)
½Ã°£
ÁÖÁ¦ ¹× ³»¿ë
¿¬ÀÚ
12:30 ~ 13:10
Welcome Ceremony
ȯ¿µ»ç
Ä·ÇÁ Program Overview (Ä·ÇÁ staff ¼Ò°³ / Âü°¡ÀÚ ¼Ò°³)
½ÅÀç±¹ ±³¼ö
(ÀÎÁ¦ÀÇ´ë ¾à¸®Çб³½Ç)
±èÁ¾·ü ±³¼ö
(ºÎ»ê¹éº´¿ø ÀÓ»ó¾à¸®Çаú)
13:10 ~ 14:00
Era of 4 P Medicine
(Personalized, Predictive, Preventive and Participatory)
½ÅÀç±¹ ±³¼ö
(ÀÎÁ¦ÀÇ´ë ¾à¸®Çб³½Ç)
14:10 ~ 15:00
½Å¾à°³¹ß°úÁ¤¿¡¼­ ÀÇ·áÀü¹®°¡ÀÇ ¿ªÇÒ, ºñÀü, öÇÐ
¾ÈÁ¾È£
(Á¦¾àÀÇÇÐȸ ȸÀå)
15:10 ~ 16:00
¼±¹è°¡ ¹Ù¶óº¸´Â ÀÇ°úÇÐÀÚÀÇ ±æ
ÇѽÂÈÆ ±³¼ö
(°¡Å縯´ëÇб³ ÀÇ°ú´ëÇÐ)
16:10 ~ 19:00
¸ÂÃãÄ¡·á ½Ã´ë¿¡ ³ªÀÇ ¾à¹°À¯ÀüÇü ¾Ë¾Æº¸±â
À¯ÀüÇü ºÐ¼® ½Ç½À I
(Genomic DNA ºÐ¸® ¹× PCR)
±èÀº¿µ ±³¼ö
(ºÎ»ê¹éº´¿ø ÀÓ»ó¾à¸®Çаú)
Â÷Àº¿µ ¿¬±¸¿ø
(ÀÎÁ¦ÀÇ´ë ¾à¸®Çб³½Ç)
19:00 ~
Group Discussion I
   : Project ¼³¸í ¹× Presentation Plan Â¥±â
Mentors


2ÀÏÂ÷ (7¿ù 14ÀÏ, È­) New drug development process (Àå¼Ò: ÀÇ°ú´ëÇÐ (¹ÌÁ¤))
½Ã°£
ÁÖÁ¦ ¹× ³»¿ë
¿¬ÀÚ
09:00 ~ 09:50
½Å¾à°³¹ß ¹°Áú µµÃâ °úÁ¤ ¹× ½Å¾àÈĺ¸¹°ÁúÀÇ ¾à¹°µ¿Å ¿¬±¸
(In Vitro ADME & Toxicology study)
±èµ¿Çö ±³¼ö
(ÀÎÁ¦ÀÇ´ë ¾à¸®Çб³½Ç)
10:00 ~ 10:50
½Å¾à°³¹ß ÀÓ»ó½ÃÇè °³¿ä ¹× °úÁ¤
Á¤Áø¾Æ ±³¼ö
(ºÎ»ê¹éº´¿ø ÀÓ»ó¾à¸®Çаú)
11:00 ~ 11:50
½Å¾à°³¹ß°úÁ¤ ±ÔÁ¦ °ü·Ã (¹ÌÁ¤)
±èÈ£Á¤ ¿¬±¸°ü
(½ÄÇ°ÀǾàÇ°¾ÈÀüó)
12:00 ~ 13:50
CTC Åõ¾î ¹× Áß½Ä
Á¤Áø¾Æ ±³¼ö
(ºÎ»ê¹éº´¿ø ÀÓ»ó¾à¸®Çаú)
À̵¿È¯ ±³¼ö
(ºÎ»ê¹éº´¿ø ÀÓ»ó¾à¸®Çаú)
14:00 ~ 16:00
PGRC/BMRC Tour
À¯ÀüÇü ºÐ¼® ½Ç½À II (SNaPshot analysis I)
(¾à¹°À¯ÀüÇüºÐ¼®ÆÀ)
16:00 ~ 16:20
Break
 
16:20 ~
Group Discussion II:
  Team Meet with Mentors to Brainstorm
  Ideas for The Team's Plan
Mentors


3ÀÏÂ÷ (7¿ù 15ÀÏ, ¼ö) Pharmacogenomics-based personalized medicine (Àå¼Ò: ÀÇ°ú´ëÇÐ(¹ÌÁ¤))
½Ã°£
ÁÖÁ¦ ¹× ³»¿ë
¿¬ÀÚ
09:00 ~ 09:10
ÇÐÀå´Ô Àλ縻¾¸  
09:10 ~ 10:00
¾à¹°À¯Àüü ¿¬±¸ °³¿ä ¹× Áø´Ü±â¼ú
½ÅÈ£Á¤ ¹Ú»ç
(ÀÎÁ¦ÀÇ´ë ¾à¹°À¯Àüü¿¬±¸¼¾ÅÍ)
10:10 ~ 11:00
Therapeutic Drug Monitoring
±èÀº¿µ ±³¼ö
(ºÎ»ê¹éº´¿ø ÀÓ»ó¾à¸®Çаú)
11:10 ~ 12:00
¹Ì·¡ÀÇÇÐÀÇ ÇöÁÖ¼Ò:
  ¾à¹°À¯Àüü ¸ÂÃãÄ¡·áÀÇ ÀÓ»óÀû¿ë»ç·Ê
±èÈ£¼÷ ±³¼ö
(ÀÎÁ¦ÀÇ´ë ¾à¸®Çб³½Ç)
12:10 ~ 18:00
À¯ÀüÇü ºÐ¼® ½Ç½À III (SNaPshot analysis II) / Áß½Ä
½Ç½ÀÁ¶±³
(¾à¹°À¯ÀüÇüºÐ¼®ÆÀ)
18:00 ~
Group Discussion III:
Discussion and Development of a Project
Proposal
Mentors


4ÀÏÂ÷ (7¿ù 16ÀÏ, ¸ñ) Scope of Clinical pharmacology (Àå¼Ò: ÀÇ°ú´ëÇÐ(¹ÌÁ¤))
½Ã°£
ÁÖÁ¦ ¹× ³»¿ë
¿¬ÀÚ
09:00 ~ 09:50
ÀÓ»ó¾à¸®ÇÐÀÚÀÇ ¿ªÇÒ
½ÅÀç±¹ ±³¼ö
(ÀÎÁ¦ÀÇ´ë ¾à¸®Çб³½Ç)
10:00 ~ 10:50
Pharmacovigilance Practice
¹ÚÂù¼± ±³¼ö
(ÇØ¿î´ë¹éº´¿ø)
11:00 ~ 11:50
ÀÓ»ó¾àÁ¦¼­ºñ½º
ÀÓ¿µÇØ °úÀå
(ºÎ»ê¹éº´¿ø ¾àÁ¦ºÎ)
12:00 ~ 13:00
Áß½Ä
 
13:00 ~ 13:50
In Silico: Beyond Medical Textbooks
±èÁ¾·ü ±³¼ö
(ºÎ»ê¹éº´¿ø ÀÓ»ó¾à¸®Çаú)
14:00 ~ 14:50
À¯ÀüÇü ºÐ¼® ½Ç½À IV (À¯ÀüÇü È®ÀÎ)
±èÈ£¼÷ ±³¼ö
(ÀÎÁ¦ÀÇ´ë ¾à¸®Çб³½Ç)
15:00 ~ 18:00
Group Discussion Final
: Presentation Áغñ
 


5ÀÏÂ÷ (7¿ù 17ÀÏ, ±Ý) Epilogue (Àå¼Ò: ºÎ»ê¹éº´¿ø ±¹Á¦È­»óȸÀǽÇ)
½Ã°£
ÁÖÁ¦ ¹× ³»¿ë
¿¬ÀÚ
09:00 ~ 12:30
Group Discussion Final: Presentation Áغñ
 
12:30 ~ 13:00
Áغñ ¹× ¼³¹®ÁöÀÛ¼º
 
13:00 ~ 15:30

Group Presentation / °¢ ÆÀº° 30ºÐ ¹ßÇ¥
(20ºÐ ¹ßÇ¥ / 10ºÐ ÁúÀÇ ÀÀ´ä)

»çȸ: À̵¿È¯ ±³¼ö
½É»çÀ§¿ø: ½ÅÀç±¹, ±èµ¿Çö, ±èÀº¿µ, ¿À¹Î°æ
15:30 ~ 16:00
Æóȸ»ç
½ÅÀç±¹ ±³¼ö
(ÀÎÁ¦ÀÇ´ë ¾à¸®Çб³½Ç)
18:30 ~ 21:00
¼Ûº° ¸¸Âù: Æóȸ½Ä ¹× ½Ã»ó½Ä
¼ö·áÁõ Àü´Þ, ½Ã»ó½Ä ÁøÇà
»çȸ: ±èÁ¾·ü ±³¼ö


 
Copyright ÀÎÁ¦´ëÇб³ ºÎ»ê¹éº´¿ø/ÀÇ°ú´ëÇÐ ¸ÂÃãÄ¡·á¸¦À§ÇÑ»ýüÁöÇ¥¿¬±¸¼¾ÅÍ ½Å¾à°³¹ßÄ·ÇÁ »ç¹«±¹
Tel: 051-890-8669, FAX: 051-893-1232, E-mail: pgrc@busanpaik.ac.kr